Debate on safety of e-cigarettes continues
2014-12-09
(Press-News.org) Opposing views on the potential impact of electronic cigarettes on public health are published in the open access journal BMC Medicine. The commentaries, by two experts, differ in their views on the topic but are united in their call for a rational discussion based on evidence.
The authors examine the WHO's recommendations earlier this year. One recommendation was that smokers should not use e-cigarettes and has now been withdrawn, and the other is that policymakers should implement their strict regulation, which is still in force.
In one of the commentaries, Peter Hajek, professor and director of the Tobacco Dependence Research Unit at Queen Mary University of London, says: "There are currently two main products competing for smokers' custom. One, the conventional cigarette, is responsible for disease and premature death in a substantial proportion of its users. It also continues to recruit new customers from among non-smoking children who try it. The other, the e-cigarette, is orders of magnitude safer. On current evidence it only appeals to smokers and generates negligible rates of regular use among non-smoking children who try it. Which one would you prefer your nicotine addicted father to use? And if your children were to try a nicotine product, which of these two would you prefer that they lay their hands on?"
He continues: "For a negative impact, e-cigarettes use would have to generate an increase in use of cigarettes. This appears a highly improbable concern. There is no precedent for a safer technology to increase the use of its less safe competitor."
In her commentary Charlotta Pisinger, associate professor, senior researcher at the Research Centre for Prevention and Health, Glostrup Hospital, Denmark, offers an opposing view: "When we compare with a conventional cigarette, the most harmful legal product on the market, everything seems harmless. For a smoker reluctant to stop smoking the e-cigarettes will most probably be a less harmful alternative - but we cannot focus on these smokers only....The potential health benefits obtained by some smokers must out-weigh the potential harm by use of ex- and never-smokers, of smokers who intended to quit but switched to e-cigarettes, of smokers' dual use and of eventual re-normalization of smoking."
She concludes: "Most probably e-cigarettes are less harmful than conventional cigarettes, but they can hardly be called safe. Consequences of e-cigarettes use must be viewed in a long-term public health perspective, including both smokers and non-smokers."
Much of the current research in this area can suffer from methodological limitations, significant conflicts of interest and inconsistent results. To address these issues so that evidence-based decisions can be made, BMC Medicine has launched an article collection on the topic. The commentaries by Peter Hajek and Charlotta Pisinger are the first in a series of debates in this special article collection. Further critiques from invited experts will be published in due course on a spectrum of topics about e-cigarettes, from research agendas, health policies and regulation, to psychiatric and public health outcomes.
INFORMATION:
Media Contact
Shane Canning
Media Manager
BioMed Central
T: +44 (0)20 3192 2243
M: +44 (0)78 2598 4543
E: shane.canning@biomedcentral.com
Notes to Editor
1. Commentary
Electronic cigarettes have a potential for huge public health benefit.
Peter Hajek
BMC Medicine 2014, 12:225
After embargo, article available at journal website here:
http://www.biomedcentral.com/1741-7015/12/225
Commentary
Why public health people are more worried than excited over e-cigarettes
Charlotta Pisinger
BMC Medicine 2014, 12:226
After embargo, article available at journal website here:
http://www.biomedcentral.com/1741-7015/12/226
During embargo, contact Shane Canning for a copy of these articles.
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
2. BMC Medicine is the flagship medical journal of the BMC series, publishing original research, commentaries and reviews that are either of significant interest to all areas of medicine and clinical practice, or provide key translational or clinical advances in a specific field. http://www.biomedcentral.com/bmcmed/
3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector. http://www.biomedcentral.com
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-09
Sophia Antipolis, 09 December 2014: Heart disease patients have been advised to avoid being outside during rush hour traffic in a paper published today in European Heart Journal.1 The position paper on air pollution and cardiovascular disease was written by experts from the European Society of Cardiology and also recommends decreasing the use of fossil fuels.
Professor Robert F. Storey, corresponding author of the paper, said: "More than 3 million deaths worldwide are caused by air pollution each year. Air pollution ranks ninth among the modifiable disease risk factors, ...
2014-12-09
There is no need to spray insecticide on walls for malaria control when people sleep under treated bed nets, according to new research.
Use of insecticide sprayed on internal walls, when combined with insecticide-treated bed nets in homes, does not protect children from malaria any more effectively than using just insecticide-treated bed nets, the research led by Durham University and the Medical Research Council's Unit in The Gambia found.
The researchers said this was important as insecticide-treated nets and insecticide sprayed on walls are commonly used for controlling ...
2014-12-09
The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal of the Royal Society of Medicine, the authors of an essay on market-access agreements for anti-cancer drugs, say that while the underlying strategy is to help reduce the likelihood of health systems paying for treatments that turn out not to be cost-effective, the agreements can also be seen as an opportunistic way for pharmaceutical manufacturers ...
2014-12-09
Donald Trump's ego may be the size of his financial empire, but that doesn't mean he's the picture of mental health. The same can be said about the self-esteem of people who are living from paycheck to paycheck, or unemployed. New research from the University of California, Berkeley, underscores this mind-wallet connection.
UC Berkeley researchers have linked inflated or deflated feelings of self-worth to such afflictions as bipolar disorder, narcissistic personality disorder, anxiety and depression, providing yet more evidence that the widening gulf between rich and ...
2014-12-09
The combined use of spraying insecticide inside homes and insecticide-treated bed nets is no better at protecting children against malaria than using bed nets alone, a study in The Gambia suggests. The findings, published in The Lancet, should encourage donors to invest their limited resources in additional bed nets, the more cost-effective solution to tackling malaria*.
Lead author Professor Steve Lindsay, a disease ecologist at Durham University in the UK explains, "Our findings do not support any universal recommendation for indoor residual spraying as an addition ...
2014-12-09
The mass die-off of nerve cells in the brains of people with Alzheimer's disease may largely occur because an entirely different class of brain cells, called microglia, begin to fall down on the job, according to a new study by researchers at the Stanford University School of Medicine.
The researchers found that, in mice, blocking the action of a single molecule on the surface of microglia restored the cells' ability to get the job done -- and reversed memory loss and myriad other Alzheimer's-like features in the animals.
The study, to be published online Dec. 8 in ...
2014-12-09
1. Breast density notification laws substantially increase costs yet save few lives
Laws requiring women to be notified of their breast density so that they may discuss supplemental screening options, including ultrasound, with their health care providers would substantially increase costs and save relatively few lives, according to an article published in Annals of Internal Medicine. More than 40 percent of women between the ages of 40 and 74 have dense breast tissue, which puts them at increased risk for breast cancer and affects how well a mammogram can detect abnormalities. ...
2014-12-09
In the most comprehensive look yet at the safety of abortion, researchers at UC San Francisco have concluded that major complications are rare, occurring less than a quarter of a percent of the time, about the same frequency as colonoscopies.
The study, published online on Monday, Dec. 8, 2014, in Obstetrics & Gynecology, analyzed data from more than 50,000 women enrolled in the Medi-Cal fee-for-service program who obtained abortions from 2009 to 2010, and looked for complications that occurred within six weeks of the procedure.
The rate is similar to what has been ...
2014-12-09
Glucose is a component of carbohydrates, and the main energy source used by brain cells.
By studying rats, a team at Imperial College London identified a mechanism that appears to sense how much glucose is reaching the brain, and prompts animals to seek more if it detects a shortfall.
The researchers believe it may play a role in driving our preference for sweet and starchy foods.
The study, funded by the Biotechnology and Biological Sciences Research Council, is published in the Journal of Clinical Investigation.
Dr James Gardiner, from the Department of Medicine, ...
2014-12-09
Patients with plasma cell dyscrasis have high amounts of an abnormal immunoglobulin, called a paraprotein, in their blood. While many patients have no outward symptoms, paraproteins can impair immune function, thicken blood, and damage organs. Plasma cell dyscrasis may be inherited, but risk factors for this disease are poorly understood. A new study in the Journal of Clinical Investigation suggests that the presence of a modified host protein is associated with plasma cell dyscrasis risk. Michael Pfreundschuh and colleagues evaluated paraproteins in blood from patients ...
LAST 30 PRESS RELEASES:
[Press-News.org] Debate on safety of e-cigarettes continues
